(Q38162118)

30 August 2017

title

Clinical studies examining the impact of obesity on breast cancer risk and prognosis (English)

1 reference

30 August 2017

0 references

2

Howard D Strickler

1 reference

30 August 2017

Rishi Jain

1

1 reference

30 August 2017

Eugene Fine

series ordinal

3

1 reference

30 August 2017

Joseph A Sparano

series ordinal

4

1 reference

30 August 2017

publication date

13 November 2013

1 reference

Journal of Mammary Gland Biology and Neoplasia

30 August 2017

published in

1 reference

30 August 2017

volume

18

1 reference

30 August 2017

issue

3-4

1 reference

30 August 2017

page(s)

257-266

1 reference

https://scigraph.springernature.com/pub.10.1007/s10911-013-9307-3

30 August 2017

exact match

0 references

cites work

Overweight, Obesity, and Mortality from Cancer in a Prospectively Studied Cohort of U.S. Adults

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Prevalence and trends in obesity among US adults, 1999-2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of body mass index on breast cancer during premenopausal and postmenopausal periods: a meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

21 January 2018

Cancer statistics, 2013

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Insulin, insulin-like growth factor-I, and risk of breast cancer in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Dual effects of weight and weight gain on breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity, mammography use and accuracy, and advanced breast cancer risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Body weight at age 20 years, subsequent weight change and breast cancer risk defined by estrogen and progesterone receptor status--the Japan public health center-based prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity as a risk factor for triple-negative breast cancers: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Body mass index, tumor characteristics, and prognosis following diagnosis of early-stage breast cancer in a mammographically screened population

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Impact of obesity on cancer survivorship and the potential relevance of race and ethnicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Fasting insulin and outcome in early-stage breast cancer: results of a prospective cohort study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Insulin-like growth factor binding proteins 1 and 3 and breast cancer outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Increased levels of COX-2 and prostaglandin E2 contribute to elevated aromatase expression in inflamed breast tissue of obese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity at diagnosis is associated with inferior outcomes in hormone receptor-positive operable breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Supervised risk predictor of breast cancer based on intrinsic subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Opposing effects of pigment epithelium-derived factor on breast cancer cell versus neuronal survival: implication for brain metastasis and metastasis-induced brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

The effect of body mass index on overall and disease-free survival in node-positive breast cancer patients treated with docetaxel and doxorubicin-containing adjuvant chemotherapy: the experience of the BIG 02-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of body mass index on tumor characteristics and disease-free survival in patients from the HER2-positive adjuvant trastuzumab trial N9831.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

American Society of Clinical Oncology clinical practice guideline: update on adjuvant endocrine therapy for women with hormone receptor-positive breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of body mass index on recurrences in tamoxifen and anastrozole treated women: an exploratory analysis from the ATAC trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity and risk of recurrence or death after adjuvant endocrine therapy with letrozole or tamoxifen in the breast international group 1-98 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Influence of letrozole and anastrozole on total body aromatization and plasma estrogen levels in postmenopausal breast cancer patients evaluated in a randomized, cross-over study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Targeting insulin and insulin-like growth factor signaling in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Metformin and breast cancer risk: a meta-analysis and critical literature review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Exemestane versus anastrozole in postmenopausal women with early breast cancer: NCIC CTG MA.27--a randomized controlled phase III trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity and insulin resistance in breast cancer--chemoprevention strategies with a focus on metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Evaluation of metformin in early breast cancer: a modification of the traditional paradigm for clinical testing of anti-cancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Angioedema in a patient with renal cell cancer treated with everolimus in combination with an angiotensin-converting enzyme inhibitor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Dual effect of metformin on breast cancer proliferation in a randomized presurgical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Weight loss with a low-carbohydrate, Mediterranean, or low-fat diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Obesity and its impact on breast cancer: tumor incidence, recurrence, survival, and possible interventions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Dietary fat reduction and breast cancer outcome: interim efficacy results from the Women's Intervention Nutrition Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Influence of a diet very high in vegetables, fruit, and fiber and low in fat on prognosis following treatment for breast cancer: the Women's Healthy Eating and Living (WHEL) randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Effect of a high-protein, low-carbohydrate diet on blood glucose control in people with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Lack of suppression of circulating free fatty acids and hypercholesterolemia during weight loss on a high-fat, low-carbohydrate diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

The metabolic response of subjects with type 2 diabetes to a high-protein, weight-maintenance diet

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Comparison of a low-fat diet to a low-carbohydrate diet on weight loss, body composition, and risk factors for diabetes and cardiovascular disease in free-living, overweight men and women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

The effects of low-carbohydrate versus conventional weight loss diets in severely obese adults: one-year follow-up of a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Banting lecture 1988. Role of insulin resistance in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Weight and metabolic outcomes after 2 years on a low-carbohydrate versus low-fat diet: a randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Targeting insulin inhibition as a metabolic therapy in advanced cancer: a pilot safety and feasibility dietary trial in 10 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10911-013-9307-3

Suppression of plasma estrogen levels by letrozole and anastrozole is related to body mass index in patients with breast cancer

21 January 2018

1 reference

12 December 2020

Upper abdominal obesity, insulin resistance and breast cancer risk

1 reference

12 December 2020

Is obesity an independent prognosis factor in woman breast cancer?

1 reference

12 December 2020

Metabolic syndrome, hyperinsulinemia, and colon cancer: a review

1 reference

12 December 2020

Undertreatment of obese women receiving breast cancer chemotherapy

1 reference

12 December 2020

Prevalence of obesity in the United States, 2009-2010.

1 reference

12 December 2020

Interactions between body mass index and hormone therapy and postmenopausal breast cancer risk (United States)

1 reference

12 December 2020

Impact of Body Mass Index on the Efficacy of Endocrine Therapy in Premenopausal Patients With Breast Cancer: An Analysis of the Prospective ABCSG-12 Trial

1 reference

12 December 2020

The FACE trial: letrozole or anastrozole as initial adjuvant therapy?

1 reference

12 December 2020

Impact of body mass index on survival outcome among women with early stage triple-negative breast cancer

1 reference

12 December 2020

Reduction in serum leptin and IGF-1 but preserved T-lymphocyte numbers and activation after a ketogenic diet in rheumatoid arthritis patients

1 reference

12 December 2020

Relationship between toxicity and obesity in women receiving adjuvant chemotherapy for breast cancer: results from cancer and leukemia group B study 8541

1 reference

12 December 2020

10.1007/S10911-013-9307-3

Identifiers

DOI

1 reference

30 August 2017

1 reference